Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials

Published:2014-04-11 Issue:9 Volume:16 Page:861-868
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ahrén B.¹,Gautier J.-F.²,Berria R.³,Stager W.³,Aronson R.⁴,Bailey C. J.⁵

Affiliation:

1. Department of Clinical Sciences; Lund University; Lund Sweden

2. Centre of Diabetes and its Complications; Lariboisière Hospital; Paris France

3. Global Medical Affairs; Sanofi; Bridgewater NJ USA

4. LMC Diabetes and Endocrinology; Toronto Canada

5. School of Life and Health Sciences, Aston University; Birmingham UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12290/fullpdf

Reference40 articles.

1. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM;DeFronzo;Diabetes,1988

2. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion;Muller;N Engl J Med,1970

3. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients;Toft-Nielsen;J Clin Endocrinol Metab,2001

4. Glucagon physiology and pathophysiology;Unger;N Engl J Med,1971

5. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans;Frank;Metabolism,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial;Diabetes, Obesity and Metabolism;2024-06-22

2. The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes;Cell Metabolism;2023-02

3. Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2019-12-26

4. Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery;European Journal of Endocrinology;2019-08

5. Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance;The Journal of Clinical Endocrinology & Metabolism;2018-09-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3